期刊文献+

提高人重组IL-6在真核细胞中表达的新途径 被引量:3

The Novel Procedures to Increase the Expression Efficiency of Recombinant Human IL-6 in Eukaryotic Cells
下载PDF
导出
摘要 为提高IL-6在真核系统中的表达效率,我们在构建真核表达载体pcDNA3IL-6的基础上,用表达载体pCI中的CMV启动子和下游所带的β-球蛋白的第一个内含子,置换了pcDNA3中的CMV启动子,构建了一种新的表达载体,使IL-6的表达水平提高了7.5倍。此外,我们还研究了pAdVAntage共转染对IL-6表达的影响,使之表达水平提高了3.6倍。以上结果为细胞因子在真核系统中的高效表达提供了有益的经验。 In order to improve the expression efficiency of recombinant IL^6 in eukaryotic cells, we constructed a new vector pcDIIL-6 to express IL-6 in eukaryotic cells on the basis of an eukaryotic vector pcDNA3IL-6 by introducin g the first intron of humanβ-globin gene into the downstream of CMV promoter in the pcDNASIL - 6. The IL-6 level expressed by pcDIIL - 6 is 7. 5 times higher than that of pcDNA3IL - 6. On the other hand , we studied the influence of pAdVAntage vector co - transfection on the expression level of IL-6 in eukaryotic cells and found the level of IL-6 is 3. 6 times higher than that of pcDNA3IL - 6. The results we got are beneficial to express cytokines with high efficiency in eukaryotic cells.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 1996年第2期135-139,共5页 Chinese Journal of Cancer Biotherapy
关键词 人重组IL-6 真核细胞 表达 基因转染 细胞因子 Interleukin 6 gene transfection intron COS-7 cell
  • 相关文献

同被引文献38

  • 1Apparailly FC, Verwaerde C, Jacquet C, et al. Adeno- virus mediated transfer of viral IL-10 gene inhibits murine collageninduced arthritis [J]. J Immunol, 1998, 160(11):5 213-5 220.
  • 2Rolland AP, Mumper RJ. Hasmid delivery to muscle: Recent advances in polymer delivery systems [J]. Adv Drug Deliv Rev, 1998,30(3) : 151 - 172.
  • 3Taskiran DM, Stefanovic Racic H, Georgescu, et al. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1 [J]. Biochem Biophys Res Commun, 1994,200(1) : 142 - 148.
  • 4Knott IM, Dieu M, Burton A, et al. Induction of cyclooxygenase by interleukin 1: comparative study between human synovial cells and chondrocytes [ J ]. J Rheumatol, 1994,21(3) :462 - 466.
  • 5Firestein GS, Berger AE, Tracey DE, etal. IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium [ J ]. J Immunol,1992,149(3) : 1 054 - 1 062.
  • 6Pelletier JP, Mineau F, Ranger P, etal. The increased synthesis of inducible nitric oxide inhibits IL-lra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation[J]. Osteoaahntis Cartilage, 1996, 4( 1 ) :77 - 84.
  • 7Sadouk MB, Pelletier JP, Tardif G. Human synovial fibroblasts co-express IL-1 receptor type I and type II mRNA.The increased level of the IL-1 receptor in osteoarthritic cells is related to an increased level of the type I receptor[J].Lab Invest, 1995,73(3) :347 - 355.
  • 8Martel Pelletier J, McCollum R, DiBatfista J, a al. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function[J]. Arthritis Rheum, 1992,35(5) :530 - 540.
  • 9Maaeddine N, Olee T, Hashimoto S, et al. Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation[J]. Arthritis Rheum,2001,44(7) : 1 633 -1 643.
  • 10Yuan GH, Masuko Hongo K, Sakata M, et al. The role of C-C chemokines and their receptors in osteoarthritis [J]. Atthrifts Rheum, 2001,44(5) : 1 056 - 1 070.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部